Advertisement
Monday, Aug 15, 2022
Outlook.com
Outlook.com

Supriya Lifescience IPO To Open On Dec 16, Price Band Fixed At Rs 265-274/Share

Supriya Lifescience’s three-day initial public offering (IPO) will conclude on December 20. The bidding for anchor investors will open on December 15, according to the company.

Supriya Lifescience IPO To Open On Dec 16, Price Band Fixed At Rs 265-274/Share
Supriya Lifescience IPO To Open On Dec 16, Price Band Fixed At Rs 265-274/Share
outlookindia.com
2021-12-13T12:08:39+05:30

Supriya Lifescience Ltd has fixed a price band of Rs 265-274 apiece for its Rs 700-crore initial share-sale, which will open for public subscription on December 16.

The three-day initial public offering (IPO) will conclude on December 20. The bidding for anchor investors will open on December 15, according to the company.

The company has cut the OFS (offer-for-sale) size to Rs 500 crore, from Rs 1,000 crore earlier.

The IPO comprises a fresh issue of equity shares worth Rs 200 crore and an offer-for-sale of up to Rs 500 crore by its promoter Satish Waman Wagh.

Currently, the promoter holds 99.26 per cent stake in the company and the promoter group owns 0.72 per cent shareholding in the firm.

Proceeds from the fresh issue will be used for funding capital expenditure requirements, repaying debt and general corporate purposes.

About 75 per cent of the issue size has been reserved for qualified institutional buyers (QIBs), 15 per cent for non-institutional investors and the remaining 10 per cent for retail investors.

Investors can bid for a minimum of 54 equity shares and in multiples thereof.

ICICI Securities and Axis Capital are the book running lead managers to the public issue.

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs), with a focus on research and development.

As of October 31, 2021, the company had product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

The company reported a net profit of Rs 123.38 crore in the fiscal year 2020-21, compared to a profit of Rs 73.37 crore in the previous year. The revenue of the company jumped to Rs 396.22 crore in FY21 from Rs 327.71 crore in FY20.

For the quarter ended on September 30, 2021, the company reported a net profit of Rs 65.96 crore with a revenue of Rs 230.06 crore.

From April 1, 2020 until October 31 2021, the company's products were exported to 86 countries to 1,296 customers including 346 distributors.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement